Related Experiment Videos
New developments in pediatric psychopharmacology.
Journal of Developmental and Behavioral Pediatrics : JDBP
|September 1, 1983
Summary
This report reviews new and existing medications for pediatric psychopharmacology, including treatments for depression, hyperactivity, and autism. Preliminary findings suggest potential applications, but caution is advised.
Area of Science:
- Pediatric Psychopharmacology
- Neurodevelopmental Disorders
- Child Psychiatry
Background:
- The field of pediatric psychopharmacology is rapidly evolving.
- There is a growing need for effective pharmacological interventions for various childhood conditions.
Purpose of the Study:
- To review recent advancements in pediatric psychopharmacology.
- To discuss new drugs and novel applications of established drugs in children.
- To outline potential indications for these treatments.
Main Methods:
- Literature review of recent developments in pediatric psychopharmacology.
- Compilation of information on specific drugs and their putative indications.
- Synthesis of preliminary data on drug efficacy and safety in pediatric populations.
Main Results:
- Imipramine, amitriptyline, lithium, piracetam, propranolol, tryptophan, clonidine, pyridoxine, and fenfluramine were reviewed.
- Putative indications include prepubertal depression, school phobia, anorexia nervosa, explosive-aggressive behavior, learning disabilities, attention deficit disorder (hyperactivity), Tourette's syndrome, autism, and Lesch-Nyhan syndrome.
- Much of the presented information is preliminary and requires cautious interpretation.
Conclusions:
- Recent developments offer potential new treatment avenues in pediatric psychopharmacology.
- Further research is needed to validate the efficacy and safety of these agents.
- Clinical application should proceed with caution due to the preliminary nature of the findings.